|
2024-01-08 |
2024-01-05 |
VP
Vente planifiée
|
Brockstedt Dirk G.
CHIEF SCIENTIFIC OFFICER
Dirigeant
|
898
-3.1%
22,78
20 456 USD
|
898
-3.1%
|
22,78
|
20 456 USD
|
|
|
2023-12-22 |
2023-12-21 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
2 500
-14.3%
21,68
54 200 USD
|
2 500
-14.3%
|
21,68
|
54 200 USD
|
|
|
2023-11-29 |
2023-11-28 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 500
-7.9%
13,72
20 580 USD
|
1 500
-7.9%
|
13,72
|
20 580 USD
|
|
|
2023-10-04 |
2023-10-03 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
2 500
-11.7%
15,77
39 425 USD
|
2 500
-11.7%
|
15,77
|
39 425 USD
|
|
|
2023-08-22 |
2023-08-18 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
2 500
-10.5%
18,92
47 300 USD
|
2 500
-10.5%
|
18,92
|
47 300 USD
|
|
|
2023-04-20 |
2023-04-19 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
5 000
-19.2%
18,88
94 400 USD
|
5 000
-19.2%
|
18,88
|
94 400 USD
|
|
|
2023-03-15 |
2023-03-14 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
2 500
+62.5%
20,05
50 125 USD
|
2 500
+62.5%
|
20,05
|
50 125 USD
|
|
|
2023-03-15 |
2023-03-14 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
600
+4.2%
19,95
11 970 USD
|
600
+4.2%
|
19,95
|
11 970 USD
|
|
|
2023-03-15 |
2023-03-14 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
400
+2.9%
18,48
7 392 USD
|
400
+2.9%
|
18,48
|
7 392 USD
|
|
|
2023-03-15 |
2023-03-14 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
1 500
+12.1%
18,75
28 125 USD
|
1 500
+12.1%
|
18,75
|
28 125 USD
|
|
|
2023-03-13 |
2023-03-07 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
5 000
-16.4%
29,62
148 100 USD
|
5 000
-16.4%
|
29,62
|
148 100 USD
|
|
|
2023-01-26 |
2023-01-24 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
5 000
-14.3%
30,00
150 000 USD
|
5 000
-14.3%
|
30,00
|
150 000 USD
|
|
|
2023-01-20 |
2023-01-19 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
5 000
-12.5%
25,56
127 800 USD
|
5 000
-12.5%
|
25,56
|
127 800 USD
|
|
|
2023-01-09 |
2023-01-05 |
V
Vente
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
742
-3.7%
21,97
16 299 USD
|
742
-3.7%
|
21,97
|
16 299 USD
|
|
|
2022-12-30 |
2022-12-29 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
5 000
-11.7%
18,03
90 150 USD
|
5 000
-11.7%
|
18,03
|
90 150 USD
|
|
|
2022-11-29 |
2022-11-28 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
5 000
-10.5%
17,87
89 350 USD
|
5 000
-10.5%
|
17,87
|
89 350 USD
|
|
|
2022-11-03 |
2022-11-02 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
5 000
-9.5%
22,32
111 600 USD
|
5 000
-9.5%
|
22,32
|
111 600 USD
|
|
|
2022-10-14 |
2022-10-13 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
2 000
-3.7%
21,52
43 040 USD
|
2 000
-3.7%
|
21,52
|
43 040 USD
|
|
|
2022-08-31 |
2022-08-30 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
2 500
-4.5%
28,13
70 325 USD
|
2 500
-4.5%
|
28,13
|
70 325 USD
|
|
|
2022-07-13 |
2022-07-11 |
V
Vente
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
2 000
-3.7%
19,95
39 900 USD
|
2 000
-3.7%
|
19,95
|
39 900 USD
|
|
|
2022-05-27 |
2022-05-25 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
63
+0.1%
12,45
785 USD
|
63
+0.1%
|
12,45
|
785 USD
|
|
|
2022-05-27 |
2022-05-25 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
1 837
+0.1%
12,45
22 880 USD
|
1 837
+0.1%
|
12,45
|
22 880 USD
|
|
|
2022-05-27 |
2022-05-25 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
63
+0.1%
12,45
785 USD
|
63
+0.1%
|
12,45
|
785 USD
|
|
|
2022-05-27 |
2022-05-25 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
1 837
+0.1%
12,45
22 880 USD
|
1 837
+0.1%
|
12,45
|
22 880 USD
|
|
|
2022-05-25 |
2022-05-24 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
538
+1.3%
12,00
6 457 USD
|
538
+1.3%
|
12,00
|
6 457 USD
|
|
|
2022-05-25 |
2022-05-24 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
15 776
+1.3%
12,00
189 345 USD
|
15 776
+1.3%
|
12,00
|
189 345 USD
|
|
|
2022-05-25 |
2022-05-24 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
538
+1.3%
12,00
6 457 USD
|
538
+1.3%
|
12,00
|
6 457 USD
|
|
|
2022-05-25 |
2022-05-24 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
15 776
+1.3%
12,00
189 345 USD
|
15 776
+1.3%
|
12,00
|
189 345 USD
|
|
|
2022-05-25 |
2022-05-23 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
338
+0.8%
12,50
4 225 USD
|
338
+0.8%
|
12,50
|
4 225 USD
|
|
|
2022-05-25 |
2022-05-23 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
9 898
+0.8%
12,50
123 718 USD
|
9 898
+0.8%
|
12,50
|
123 718 USD
|
|
|
2022-05-25 |
2022-05-23 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
338
+0.8%
12,50
4 225 USD
|
338
+0.8%
|
12,50
|
4 225 USD
|
|
|
2022-05-25 |
2022-05-23 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
9 898
+0.8%
12,50
123 718 USD
|
9 898
+0.8%
|
12,50
|
123 718 USD
|
|
|
2022-05-12 |
2022-05-10 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
41 250
+inf%
10,67
440 199 USD
|
41 250
+inf%
|
10,67
|
440 199 USD
|
|
|
2022-05-12 |
2022-05-10 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
1 208 750
+inf%
10,67
12 899 176 USD
|
1 208 750
+inf%
|
10,67
|
12 899 176 USD
|
|
|
2022-05-12 |
2022-05-10 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
400
+11.1%
10,62
4 248 USD
|
400
+11.1%
|
10,62
|
4 248 USD
|
|
|
2022-05-12 |
2022-05-10 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
600
+20.0%
10,49
6 294 USD
|
600
+20.0%
|
10,49
|
6 294 USD
|
|
|
2022-05-12 |
2022-05-10 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
1 000
+50.0%
10,51
10 510 USD
|
1 000
+50.0%
|
10,51
|
10 510 USD
|
|
|
2022-05-12 |
2022-05-10 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
500
+38.5%
11,30
5 650 USD
|
500
+38.5%
|
11,30
|
5 650 USD
|
|
|
2022-05-12 |
2022-05-10 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
2 500
+22.1%
11,80
29 500 USD
|
2 500
+22.1%
|
11,80
|
29 500 USD
|
|
|
2022-05-12 |
2022-05-10 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
2 000
+21.5%
10,54
21 080 USD
|
2 000
+21.5%
|
10,54
|
21 080 USD
|
|
|
2022-05-12 |
2022-05-10 |
AP
Achat planifié
|
Young Rodney KB
Chief Financial Officer
Dirigeant
|
5 000
+98.3%
10,53
52 650 USD
|
5 000
+98.3%
|
10,53
|
52 650 USD
|
|
|
2022-05-12 |
2022-05-10 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
41 250
+inf%
10,67
440 199 USD
|
41 250
+inf%
|
10,67
|
440 199 USD
|
|
|
2022-05-12 |
2022-05-10 |
A
Achat
|
COLUMN GROUP II, LP
Actionnaire important
|
1 208 750
+inf%
10,67
12 899 176 USD
|
1 208 750
+inf%
|
10,67
|
12 899 176 USD
|
|
|
2022-05-05 |
2022-05-04 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
720
-3.5%
15,05
10 836 USD
|
720
-3.5%
|
15,05
|
10 836 USD
|
|
|
2022-04-12 |
2022-04-11 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
2 647
-11.8%
23,05
61 013 USD
|
2 647
-11.8%
|
23,05
|
61 013 USD
|
|
|
2022-04-07 |
2022-04-06 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
3 000
-5.3%
22,96
68 880 USD
|
3 000
-5.3%
|
22,96
|
68 880 USD
|
|
|
2022-03-14 |
2022-03-11 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
2 648
-11.8%
23,91
63 314 USD
|
2 648
-11.8%
|
23,91
|
63 314 USD
|
|
|
2022-02-28 |
2022-02-28 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
3 000
-5.1%
18,79
56 370 USD
|
3 000
-5.1%
|
18,79
|
56 370 USD
|
|
|
2022-02-14 |
2022-02-11 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
2 647
-11.8%
22,47
59 478 USD
|
2 647
-11.8%
|
22,47
|
59 478 USD
|
|
|
2022-01-14 |
2022-01-13 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
3 000
-4.9%
30,67
92 010 USD
|
3 000
-4.9%
|
30,67
|
92 010 USD
|
|
|
2022-01-13 |
2022-01-11 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
2 648
-11.8%
32,16
85 160 USD
|
2 648
-11.8%
|
32,16
|
85 160 USD
|
|
|
2022-01-06 |
2022-01-05 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
2 000
-3.2%
40,00
80 000 USD
|
2 000
-3.2%
|
40,00
|
80 000 USD
|
|
|
2021-12-13 |
2021-12-10 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
2 647
-11.8%
30,88
81 739 USD
|
2 647
-11.8%
|
30,88
|
81 739 USD
|
|
|
2021-12-06 |
2021-12-03 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
3 000
-5.0%
32,26
96 780 USD
|
3 000
-5.0%
|
32,26
|
96 780 USD
|
|
|
2021-12-10 |
2021-11-11 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
2 648
-11.8%
35,69
94 507 USD
|
2 648
-11.8%
|
35,69
|
94 507 USD
|
|
|
2021-10-19 |
2021-10-18 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
500
+5.7%
30,70
15 350 USD
|
500
+5.7%
|
30,70
|
15 350 USD
|
|
|
2021-10-15 |
2021-10-13 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
400
+4.8%
29,69
11 876 USD
|
400
+4.8%
|
29,69
|
11 876 USD
|
|
|
2021-10-14 |
2021-10-13 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
3 000
-4.8%
29,69
89 070 USD
|
3 000
-4.8%
|
29,69
|
89 070 USD
|
|
|
2021-10-12 |
2021-10-11 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
2 647
-11.8%
30,78
81 475 USD
|
2 647
-11.8%
|
30,78
|
81 475 USD
|
|
|
2021-09-29 |
2021-09-27 |
V
Vente
|
COLUMN GROUP II, LP
Actionnaire important
|
625
-100.0%
34,94
21 840 USD
|
625
-100.0%
|
34,94
|
21 840 USD
|
|
|
2021-09-29 |
2021-09-27 |
V
Vente
|
COLUMN GROUP II, LP
Actionnaire important
|
1 114
-100.0%
34,97
38 951 USD
|
1 114
-100.0%
|
34,97
|
38 951 USD
|
|
|
2021-09-29 |
2021-09-27 |
V
Vente
|
COLUMN GROUP II, LP
Actionnaire important
|
7 500
-100.0%
34,48
258 606 USD
|
7 500
-100.0%
|
34,48
|
258 606 USD
|
|
|
2021-09-14 |
2021-09-13 |
V
Vente
|
COLUMN GROUP II, LP
Actionnaire important
|
4 788
-11.6%
35,28
168 942 USD
|
4 788
-11.6%
|
35,28
|
168 942 USD
|
|
|
2021-09-14 |
2021-09-13 |
V
Vente
|
COLUMN GROUP II, LP
Actionnaire important
|
4 726
-6.1%
35,27
166 692 USD
|
4 726
-6.1%
|
35,27
|
166 692 USD
|
|
|
2021-09-14 |
2021-09-13 |
V
Vente
|
COLUMN GROUP II, LP
Actionnaire important
|
4 803
-6.2%
35,25
169 309 USD
|
4 803
-6.2%
|
35,25
|
169 309 USD
|
|
|
2021-09-14 |
2021-09-10 |
V
Vente
|
COLUMN GROUP II, LP
Actionnaire important
|
7 231
-14.9%
35,19
254 494 USD
|
7 231
-14.9%
|
35,19
|
254 494 USD
|
|
|
2021-09-14 |
2021-09-10 |
V
Vente
|
COLUMN GROUP II, LP
Actionnaire important
|
7 320
-8.7%
35,19
257 573 USD
|
7 320
-8.7%
|
35,19
|
257 573 USD
|
|
|
2021-09-14 |
2021-09-10 |
V
Vente
|
COLUMN GROUP II, LP
Actionnaire important
|
7 187
-8.5%
35,19
252 940 USD
|
7 187
-8.5%
|
35,19
|
252 940 USD
|
|
|
2021-09-13 |
2021-09-10 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
2 648
-11.8%
35,78
94 745 USD
|
2 648
-11.8%
|
35,78
|
94 745 USD
|
|
|
2021-06-21 |
2021-06-16 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
5
+1.7%
31,61
158 USD
|
5
+1.7%
|
31,61
|
158 USD
|
|
|
2021-06-21 |
2021-06-16 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
100
+1.5%
31,53
3 153 USD
|
100
+1.5%
|
31,53
|
3 153 USD
|
|
|
2021-06-21 |
2021-06-16 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
100
+1.5%
31,56
3 156 USD
|
100
+1.5%
|
31,56
|
3 156 USD
|
|
|
2021-06-21 |
2021-06-16 |
A
Achat
|
Robbins Wendye
Administrateur non-exécutif
|
500
+8.2%
31,54
15 770 USD
|
500
+8.2%
|
31,54
|
15 770 USD
|
|
|
2021-06-17 |
2021-06-15 |
VP
Vente planifiée
|
HO WILLIAM
Chief Medical Officer
Dirigeant
|
1 000
-1.7%
43,26
43 260 USD
|
1 000
-1.7%
|
43,26
|
43 260 USD
|
|
|
2021-06-15 |
2021-06-11 |
VP
Vente planifiée
|
Brockstedt Dirk G.
Chief Scientific Officer
Dirigeant
|
2 647
-11.8%
18,55
49 102 USD
|
2 647
-11.8%
|
18,55
|
49 102 USD
|
|
